Feline Herpesvirus Management: Living With a Cat That Will Always Have It: Quick Visual Guide
This infographic summarizes practical decision points and routine priorities from the article for cat owners.
Feline Herpesvirus Management: Living With a Cat That Will Always Have It: response path
Health Lens
| Health Lens | What to Watch | Why It Matters | Best Next Move |
|---|---|---|---|
| Early change | Small shifts in appetite, energy, or output | Minor signs often come first | Document the pattern early |
| Escalation | Fast decline, pain, bleeding, breathing trouble, or collapse | These can cross into urgent territory | Move up the response level quickly |
| Environment | Heat, hygiene, crowding, or setup stress | Care conditions often worsen health issues | Fix the setup alongside treatment |
| Recovery tracking | Whether the trend improves after intervention | Shows if the first plan was enough | Assuming one good hour means the issue is over |
Feline Herpesvirus Management: Living With a Cat That Will Always Have It: review checklist
| Use early changes as signals to observe and document | |
| Escalate quickly when breathing, bleeding, collapse, or severe pain appear | |
| Support the environment while you pursue treatment | |
| Wait for dramatic decline before taking the pattern seriously | |
| Assume a brief improvement means the issue is solved |
Feline Herpesvirus Management: Living With a Cat That Will Always Have It works best when owners translate the article into a repeatable routine instead of relying on memory or one-off fixes.
If the situation in feline herpesvirus management: living with a cat that will always have it includes rapid decline, obvious distress, or a setup problem you cannot control safely, escalate faster rather than waiting for the pattern to fix itself.
Feline herpesvirus-1 (FHV-1) establishes lifelong latent infection in 97% of exposed cats. There is no cure. The goal of management is reducing frequency and severity of flare-ups through stress minimization, L-lysine supplementation (debated), antiviral eye drops during ocular flares, and supportive care during respiratory episodes.
The Latency Cycle
After initial infection -- typically in kittens from an infected mother -- FHV-1 travels up sensory nerves and establishes permanent latency in the trigeminal ganglion. The virus becomes dormant, invisible to the immune system, and undetectable on PCR. Stress triggers reactivation: the virus travels back down nerve pathways and replicates in epithelial tissue, causing recurrent symptoms. Classic triggers: new pets, moving, veterinary visits, boarding, surgery, other illness, seasonal changes. Approximately 45% of cats shed virus after experimental corticosteroid administration (a surrogate for physiological stress).
Recognizing a Flare
Respiratory flares: nasal discharge (starts clear, may become yellow-green with secondary bacterial infection), sneezing fits, congestion causing mouth breathing, fever. Ocular flares: conjunctivitis (red, swollen conjunctiva), ocular discharge, corneal ulceration (dendritic ulcers visible with fluorescein staining at a vet). Corneal ulcers are painful and require prompt treatment -- untreated, they can progress to corneal sequestrum or even perforation. Skin flares are less common: facial ulceration at the nostrils or mouth corners.
Treatment During Flares
Ocular flares: topical idoxuridine 0.1%, trifluridine 1%, or cidofovir 0.5% eye drops applied every 6-8 hours for 7-10 days significantly reduce corneal ulcer healing time. Cidofovir has the advantage of twice-daily dosing. Oral famciclovir (90 mg/kg every 8 hours -- this is cat-specific dosing, not human doses) reduces viral replication systemically and is the preferred oral antiviral for severe cases. Do not use acyclovir in cats -- poor oral bioavailability and potential nephrotoxicity. Secondary bacterial infections require antibiotics (doxycycline 5 mg/kg once daily or azithromycin 5-10 mg/kg once daily).
L-Lysine: The Controversy
L-lysine supplementation (250-500 mg twice daily) has been used for decades based on the hypothesis that lysine competes with arginine, which FHV-1 requires for replication. However, a 2015 systematic review in BMC Veterinary Research found no convincing evidence of benefit, and some studies found lysine supplementation increased shedding in some cats. The AAFP 2020 guidelines removed lysine from recommended management. The supplement appears low-risk but evidence for efficacy is poor. Some veterinarians continue recommending it; discuss with your vet.
Reducing Flare Frequency
Stress minimization is the most evidence-based intervention: Feliway diffusers (synthetic feline facial pheromone) reduce behavioral stress markers. Environmental enrichment, consistent routine, and slow introductions for new pets help. For cats with severe recurrent disease, daily prophylactic famciclovir has been used in some cases but evidence is limited. Ensure the cat is up to date on FHV-1 vaccination -- while vaccines do not eliminate infection, they reduce severity and viral shedding during flares.
Sources: Thiry E et al., Feline herpesvirus infection, ABCD guidelines; Gould D, Feline herpesvirus-1: ocular manifestations, diagnosis, and treatment options, Journal of Feline Medicine and Surgery 2011; Bol S, Bunnik EM, Lysine supplementation is not effective for the prevention or treatment of FHV-1, BMC Veterinary Research 2015; AAFP Feline Vaccination Advisory Panel guidelines.